Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125198934 | 12519893 | 4 | F | 20160301 | 20160725 | 20160630 | 20160803 | EXP | IT-SA-2016SA103274 | AVENTIS | 72.00 | YR | E | M | Y | 0.00000 | 20160803 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125198934 | 12519893 | 1 | PS | APIDRA | INSULIN GLULISINE | 1 | Unknown | DOSE-4-6-4 IU AT PRINCIPAL MEALS | 5S372A | 21629 | |||||||||
| 125198934 | 12519893 | 2 | SS | APIDRA | INSULIN GLULISINE | 1 | Unknown | UNKNOWN | 21629 | ||||||||||
| 125198934 | 12519893 | 3 | SS | LANTUS | INSULIN GLARGINE | 1 | Unknown | UNK | 21081 | 6 | IU | ||||||||
| 125198934 | 12519893 | 4 | SS | LANTUS | INSULIN GLARGINE | 1 | Unknown | UNK | 21081 | 3 | IU | ||||||||
| 125198934 | 12519893 | 5 | SS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | DOSE-8M | U | UNKNOWN | 0 | BID | |||||||
| 125198934 | 12519893 | 6 | SS | MADOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | Oral | DOSE-HALF?TAP AT?PRINCIP?AL?MEALS | U | UNKNOWN | 0 | ||||||||
| 125198934 | 12519893 | 7 | SS | AVODART | DUTASTERIDE | 1 | Oral | FREQ-IN MORNING | U | UNKNOWN | 0 | .5 | MG | CAPSULE, SOFT | |||||
| 125198934 | 12519893 | 8 | SS | UROREC | SILODOSIN | 1 | Oral | FREQ-IN MORNING | U | UNKNOWN | 0 | .8 | MG | ||||||
| 125198934 | 12519893 | 9 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | UNKNOWN | 0 | |||||||||
| 125198934 | 12519893 | 10 | SS | NEUPRO | ROTIGOTINE | 1 | Transdermal | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125198934 | 12519893 | 1 | Diabetes mellitus |
| 125198934 | 12519893 | 2 | Diabetes mellitus |
| 125198934 | 12519893 | 3 | Diabetes mellitus |
| 125198934 | 12519893 | 4 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125198934 | 12519893 | HO |
| 125198934 | 12519893 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125198934 | 12519893 | Capillary disorder | |
| 125198934 | 12519893 | Dizziness | |
| 125198934 | 12519893 | Hyperglycaemia | |
| 125198934 | 12519893 | Hypoglycaemia | |
| 125198934 | 12519893 | Joint swelling | |
| 125198934 | 12519893 | Nausea | |
| 125198934 | 12519893 | Paraesthesia | |
| 125198934 | 12519893 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |